Our data from the analysis of a large collection brains from mice infected with 15 distinct prion agent strains suggest CD44 expression fulfils these criteria and can be used as a novel marker to detect reactive astrocyte heterogeneity during CNS prion disease. This evidence concerns the gene CD44 and prion disease.